Tue, October 20, 2009
Mon, October 19, 2009
Fri, October 16, 2009
Thu, October 15, 2009
Wed, October 14, 2009
Tue, October 13, 2009
Mon, October 12, 2009
Fri, October 9, 2009
Thu, October 8, 2009
Wed, October 7, 2009
Tue, October 6, 2009
Mon, October 5, 2009
Sun, October 4, 2009
Fri, October 2, 2009
Thu, October 1, 2009
Wed, September 30, 2009
Tue, September 29, 2009
Mon, September 28, 2009
Fri, September 25, 2009
Thu, September 24, 2009
Wed, September 23, 2009
Tue, September 22, 2009
Mon, September 21, 2009
Fri, September 18, 2009
Thu, September 17, 2009
Wed, September 16, 2009
Tue, September 15, 2009
Mon, September 14, 2009
Fri, September 11, 2009
Thu, September 10, 2009
Wed, September 9, 2009
Tue, September 8, 2009
Sun, September 6, 2009
Fri, September 4, 2009
Thu, September 3, 2009
Wed, September 2, 2009
Tue, September 1, 2009
Mon, August 31, 2009
Fri, August 28, 2009

BiomedReports.Com: Intriguing Revelations: Deciphering CEL-SCI's H1N1 Flu Play


//health-fitness.news-articles.net/content/2009/ .. lations-deciphering-cel-sci-s-h1n1-flu-play.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


LOS ANGELES, CA--(Marketwire - September 23, 2009) - BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has published a new report about CEL-SCI Corporation's (NYSE Amex: [ CVM ]) new H1N1 flu drug candidate.

Hype versus substance. Perception versus reality. During the past week, there has been much debate regarding the work being done by CEL-SCI in the pandemic influenza space, but previously published data may help shed new light on the L.E.A.P.S platform which is being used to develop the treatment.

Are there applications for CEL-SCI's work beyond the scope and urgency of the current pandemic that may open up other lucrative markets?

The new article can be read in their entirety at BioMedReports.Com:

[ http://biomedreports.com/component/content/article/56-top-leading-news/10621-intriguing-revelations-deciphering-cel-scis-h1n1-flu-play.html ]

Biotech investors interested in accessing the news portal's complete database of clinical trials and upcoming FDA decisions can access that information here:

[ http://biomedreports.com/fda-calendar/fda-calendar.html ]

For more biomedical sector and investment news go to[ http://BioMedReports.com ]


Publication Contributing Sources

Similar Health and Fitness Publications